Developer docs
API playgroundTry for free, no card

Search company profiles

Bewelab SA

Full company profile

uuid0003k59

Namestring
Bewelab SA
Legal namestring
BEWE LAB SA
Websiteurl
bewe.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Bewe Lab SA is a Swiss digital health company that has developed Bewe Coaching, a neuroscience-backed mobile game designed to reduce food cravings by retraining brain reward pathways through neuroplasticity-based interventions. Founded in 2023 as a spin-off from the Laboratory of Neurorehabilitation Sciences at the University of Fribourg, the company leverages more than 15 years of research led by co-founder and CSO Professor Lucas Spierer. Its core product requires only 3-5 minutes of daily gameplay for 1-3 weeks and has been validated through randomized controlled trials published in Royal Society Open Science and Nature Scientific Reports, demonstrating a 21% reduction in cravings and a 28% reduction in unhealthy food consumption, with effects persisting beyond 6 months and an 80% trial retention rate.

The company operates a hybrid go-to-market combining product-led consumer growth through iOS and Google Play (a free Swiss soda module plus additional food category modules sold as in-app purchases at approximately CHF 7.90 each) with enterprise B2B sales targeting health insurers (including CSS), healthcare professionals, obesity centers (CPNO), and employers for corporate wellness programs. The proprietary Motivational Salience Index (MSI) is a patented behavioral measurement that analyzes touchscreen micro-behaviors — reaction time, inhibitory control, choice speed, and finger trajectory — during Go/NoGo and approach-avoidance tasks, powering a real-time adaptive feedback loop that shifts intervention targets as stimuli become less salient.

Revenue mechanics are split between consumer in-app purchases and B2B enterprise licensing, with additional grant funding from public innovation programs (Venture Kick, Innosuisse, FIT, Future of Health Grant, Fribourg Innovation, SNF) supporting R&D. Strategic partnerships with the Swiss Data Science Center, Canton de Vaud, CHUV, and UCSF underpin ongoing scientific validation, AI/data-science development, and clinical extensions (including gestational diabetes). Total disclosed funding across equity and grants is approximately CHF 2.5 million, with the most recent $1.5 million round led by Arcanys Ventures in February 2026.

Short descriptiontext

Bewe Lab SA is a Swiss digital health company offering a neuroscience-backed mobile game that retrains the brain's reward system to reduce food cravings. It serves consumers via app stores and partners with health insurers, healthcare providers, and employers for wellness distribution.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFribourg, Switzerland
HQ citystring
Fribourg
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health intervention, neuroscience mobile games, food craving reduction, behavioral health app, gamified cognitive therapy
Industry2 codes
PRIMARYHLAFACAK
Eating Disorder Treatment Programs
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
SECONDARYHSADAFAO
Corporate/Workplace Nutrition & Weight Management Programs
Product category
Digital Health Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Consumer In-App Purchases (Freemium)
TypeFreemium
Description

The app follows a freemium model where the Swiss soda module is free. Additional food categories (such as chocolate, chips, or other targeted food types) are available as paid in-app purchases at an average cost of CHF 7.90 per category.

bewe.com
2B2B Enterprise Licensing
TypeSubscription Recurring
Description

Bewe Lab generates revenue through enterprise partnerships with health insurers, healthcare professionals, and employers who license or distribute the app to their members, patients, or employees as part of wellness and prevention programs.

bewe.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details2 tiers
1Free soda module for Swiss users
ModelFreemiumBilling cadenceOthers
Notes

The Swiss soda module is completely free. This serves as a free trial/demo for the core intervention.

bewe.com
2Additional food category modules (in-app purchase)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Average cost of CHF 7.90 per food category module (e.g., chocolate, chips, desserts). Users can purchase individual modules for different food craving targets.

bewe.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

Bewe Lab develops Bewe Coaching, a neuroscience-backed mobile gaming app that retrains the brain's reward system to reduce food cravings through neuroplasticity-based behavioral interventions. Users play 3-5 minutes daily for 1-3 weeks, with mini-games (Go/NoGo, approach-avoidance, time-constrained choice) targeting specific food categories such as sodas (free Swiss module) and additional paid modules (e.g., chocolate, chips) at CHF 7.90 per category.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 21% reduction in cravings
+6 more records
Product overview1 text field

Bewe Lab SA offers Bewe Coaching, a standalone neuroscience-backed gamified mobile application that retrains the brain's reward system to reduce food cravings. The core Bewe Coaching app is complemented by the Bewe Profiler assessment tool for evaluating user craving profiles. Within the app, users access category-specific intervention modules (starting with a free Sodas module, with additional food categories available for purchase) that deliver 3-5 minute daily gameplay sessions over 1-3 weeks to achieve lasting behavioral change.

Product and service2 records
1Bewe Coaching
CategoryDigital Health Mobile App
Description

A neuroscience-backed gamified mobile app that retrains the brain's reward system to reduce food cravings. Users play 3-5 minutes daily for 1-3 weeks. The Swiss Sodas module is free; additional food category modules (chocolate, chips, etc.) are purchasable as in-app purchases at an average of CHF 7.90 per category. Backed by over 15 years of neuroscience research and validated through randomized controlled trials showing 21% reduction in cravings and 28% reduction in unhealthy food consumption.

2Bewe Profiler
CategoryBehavioral Assessment Tool
Description

An assessment tool that evaluates body stress and craving profiles using custom behavioral tests, helping users understand their relationship with food triggers before beginning the coaching intervention.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with SDSC for data-science validation of the Motivational Salience Index (MSI), bringing statistical rigor expected by clinicians, regulators, and payers. SDSC is partnered with Canton of Vaud to provide CHF 7.5 million in AI technical support funding.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Vaud government partnership providing CHF 7.5 million in funding for AI technical support to companies embedding AI into Vaud's economy. Bewe was selected in second call for projects under this partnership.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Bewe is a spin-off from the Laboratory of Neurorehabilitation Sciences at University of Fribourg. Co-founder Prof. Lucas Spierer leads the lab. Ongoing research collaboration and academic validation of the technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Exploratory collaboration with CHUV's gestational diabetes unit for using the Motivational Salience Index (MSI) in perinatal care, where self-reporting is notoriously unreliable.

5Centre Pluridisciplinaire Neuchâtelois pour l'Obésité (CPNO)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Collaboration with obesity treatment center for referral and distribution of Bewe to patients with obesity and weight management needs.

bewe.com
6Alliance Obésité (Eurobesitas)
Strategic tierSecondaryTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with European obesity alliance for referral and distribution of Bewe to patients across obesity treatment networks.

bewe.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Health insurer partnership to offer Bewe as part of policyholder wellness programs, with potential for reimbursement of the digital health intervention.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Collaboration with University of California San Francisco medical school for research and academic validation of the neuroscience-based approach.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Healthcare provider partnership for potential distribution of Bewe to patients in health system.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Noom
TypeDirect peer
Description

Consumer-facing digital weight management app combining psychology, coaching, and food logging. Directly comparable as a behavioral-change weight-management platform competing for the same individual consumers and B2B wellness buyers.

TypeDirect peer
Description

Digital therapeutic for type 2 diabetes reversal and weight management, sold enterprise to health plans and employers. Comparable as a clinically validated, payer-reimbursed digital therapeutic addressing diet-related metabolic conditions.

TypeDirect peer
Description

Digital therapeutic app for diabetes self-management with consumer and B2B channels. Comparable as a clinically validated, gamified chronic-condition digital health app with payer/employer distribution.

TypeBroad incumbent
Description

Established incumbent in weight management with consumer subscription and B2B wellness offerings. A broad competitor in the same end-customer problem space (weight/craving reduction) but with a much wider portfolio.

TypeDirect peer
Description

Digital therapeutics platform for chronic disease management including diabetes and cardiovascular, with payer and provider B2B channels. Comparable as an enterprise digital therapeutic targeting diet-related chronic conditions.

TypeDirect peer
Description

Digital therapeutic platform targeting diabetes prevention and weight management via behavior change, with enterprise B2B distribution through health plans and employers — closely aligned with Bewe's B2B insurance/employer strategy.

TypeDirect peer
Description

Digital therapeutic company delivering cognitive interventions through video games (e.g., EndeavorRx). Closely aligned with Bewe's game-based neuroscience approach and digital therapeutic regulatory positioning.

8CureApp
TypeEmerging player
Description

Japanese digital therapeutic company developing software-based treatments for nicotine addiction and other behavioral conditions. Comparable as an emerging digital therapeutics player using software interventions for addiction/craving reduction.

TypeDirect peer
Description

European digital health platform for lifestyle change and weight management, sold through insurers and healthcare providers. Comparable in geography, B2B payer distribution model, and behavioral-change focus.

TypeBroad incumbent
Description

Digital mental health and mindfulness platform with B2B enterprise distribution. Comparable as a behavioral-change digital health app monetized via consumer subscriptions and employer/payer partnerships.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bewelab SA

Digital Health Softwarebewe.com

Bewe Lab SA is a Swiss digital health company offering a neuroscience-backed mobile game that retrains the brain's reward system to reduce food cravings. It serves consumers via app stores and partners with health insurers, healthcare providers, and employers for wellness distribution.

What Bewelab SA does

Bewe Lab SA is a Swiss digital health company that has developed Bewe Coaching, a neuroscience-backed mobile game designed to reduce food cravings by retraining brain reward pathways through neuroplasticity-based interventions. Founded in 2023 as a spin-off from the Laboratory of Neurorehabilitation Sciences at the University of Fribourg, the company leverages more than 15 years of research led by co-founder and CSO Professor Lucas Spierer. Its core product requires only 3-5 minutes of daily gameplay for 1-3 weeks and has been validated through randomized controlled trials published in Royal Society Open Science and Nature Scientific Reports, demonstrating a 21% reduction in cravings and a 28% reduction in unhealthy food consumption, with effects persisting beyond 6 months and an 80% trial retention rate.

The company operates a hybrid go-to-market combining product-led consumer growth through iOS and Google Play (a free Swiss soda module plus additional food category modules sold as in-app purchases at approximately CHF 7.90 each) with enterprise B2B sales targeting health insurers (including CSS), healthcare professionals, obesity centers (CPNO), and employers for corporate wellness programs. The proprietary Motivational Salience Index (MSI) is a patented behavioral measurement that analyzes touchscreen micro-behaviors — reaction time, inhibitory control, choice speed, and finger trajectory — during Go/NoGo and approach-avoidance tasks, powering a real-time adaptive feedback loop that shifts intervention targets as stimuli become less salient.

Revenue mechanics are split between consumer in-app purchases and B2B enterprise licensing, with additional grant funding from public innovation programs (Venture Kick, Innosuisse, FIT, Future of Health Grant, Fribourg Innovation, SNF) supporting R&D. Strategic partnerships with the Swiss Data Science Center, Canton de Vaud, CHUV, and UCSF underpin ongoing scientific validation, AI/data-science development, and clinical extensions (including gestational diabetes). Total disclosed funding across equity and grants is approximately CHF 2.5 million, with the most recent $1.5 million round led by Arcanys Ventures in February 2026.

Bewelab SA firmographics

Firmographics
Name
Bewelab SA
Legal name
BEWE LAB SA
Website
https://bewe.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Bewe Lab SA is a Swiss digital health company offering a neuroscience-backed mobile game that retrains the brain's reward system to reduce food cravings. It serves consumers via app stores and partners with health insurers, healthcare providers, and employers for wellness distribution.
Ownership category
akta.pro rank

Bewelab SA industry classification

Industry
Product category
Digital Health Software
akta.pro industry
PRIMARYHLAFACAK
Eating Disorder Treatment Programs
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
SECONDARYHSADAFAO
Corporate/Workplace Nutrition & Weight Management Programs

Keywords

  • Digital health intervention
  • Neuroscience mobile games
  • Food craving reduction
  • Behavioral health app
  • Gamified cognitive therapy

Where Bewelab SA is headquartered

Location

Headquarters

HQ city
Fribourg
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

Bewelab SA business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Consumer In-App Purchases (Freemium): The app follows a freemium model where the Swiss soda module is free. Additional food categories (such as chocolate, chips, or other targeted food types) are available as paid in-app purchases at an average cost of CHF 7.90 per category.
  2. B2B Enterprise Licensing: Bewe Lab generates revenue through enterprise partnerships with health insurers, healthcare professionals, and employers who license or distribute the app to their members, patients, or employees as part of wellness and prevention programs.

Pricing tiers

ModelBillingPrice
FreemiumOthersFree soda module for Swiss users
Unit PricingPay-as-you-goAdditional food category modules (in-app purchase)

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Bewelab SA product offering

Product offering

Core offering

Bewe Lab develops Bewe Coaching, a neuroscience-backed mobile gaming app that retrains the brain's reward system to reduce food cravings through neuroplasticity-based behavioral interventions. Users play 3-5 minutes daily for 1-3 weeks, with mini-games (Go/NoGo, approach-avoidance, time-constrained choice) targeting specific food categories such as sodas (free Swiss module) and additional paid modules (e.g., chocolate, chips) at CHF 7.90 per category.

Product overview

Bewe Lab SA offers Bewe Coaching, a standalone neuroscience-backed gamified mobile application that retrains the brain's reward system to reduce food cravings. The core Bewe Coaching app is complemented by the Bewe Profiler assessment tool for evaluating user craving profiles. Within the app, users access category-specific intervention modules (starting with a free Sodas module, with additional food categories available for purchase) that deliver 3-5 minute daily gameplay sessions over 1-3 weeks to achieve lasting behavioral change.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bewe Coaching A neuroscience-backed gamified mobile app that retrains the brain's reward system to reduce food cravings. Users play 3-5 minutes daily for 1-3 weeks. The Swiss Sodas module is free; additional food category modules (chocolate, chips, etc.) are purchasable as in-app purchases at an average of CHF 7.90 per category. Backed by over 15 years of neuroscience research and validated through randomized controlled trials showing 21% reduction in cravings and 28% reduction in unhealthy food consumption.
  • Bewe Profiler An assessment tool that evaluates body stress and craving profiles using custom behavioral tests, helping users understand their relationship with food triggers before beginning the coaching intervention.

Quantifiable outcome

  • 21% reduction in cravings
  • +6 more outcomes

Companies that use Bewelab SA

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Bewelab SA technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Bewelab SA partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, secondary and minor.

  • Swiss Data Science Center (SDSC)coreStrategic or Co-development PartnerCollaboration with SDSC for data-science validation of the Motivational Salience Index (MSI), bringing statistical rigor expected by clinicians, regulators, and payers. SDSC is partnered with Canton of Vaud to provide CHF 7.5 million in AI technical support funding.
  • Canton de VaudcoreStrategic or Co-development PartnerVaud government partnership providing CHF 7.5 million in funding for AI technical support to companies embedding AI into Vaud's economy. Bewe was selected in second call for projects under this partnership.
  • University of Fribourg (Uni Fribourg)coreStrategic or Co-development PartnerBewe is a spin-off from the Laboratory of Neurorehabilitation Sciences at University of Fribourg. Co-founder Prof. Lucas Spierer leads the lab. Ongoing research collaboration and academic validation of the technology.
  • CHUV (Centre Hospitalier Universitaire Vaudois)coreStrategic or Co-development PartnerExploratory collaboration with CHUV's gestational diabetes unit for using the Motivational Salience Index (MSI) in perinatal care, where self-reporting is notoriously unreliable.
  • Centre Pluridisciplinaire Neuchâtelois pour l'Obésité (CPNO)coreChannel Partner/ Reseller/ DistributorCollaboration with obesity treatment center for referral and distribution of Bewe to patients with obesity and weight management needs.
  • Alliance Obésité (Eurobesitas)secondaryChannel Partner/ Reseller/ DistributorPartnership with European obesity alliance for referral and distribution of Bewe to patients across obesity treatment networks.
  • CSS InsurancecoreChannel Partner/ Reseller/ DistributorHealth insurer partnership to offer Bewe as part of policyholder wellness programs, with potential for reimbursement of the digital health intervention.
  • UCSF School of MedicinesecondaryStrategic or Co-development PartnerCollaboration with University of California San Francisco medical school for research and academic validation of the neuroscience-based approach.
  • Salinas Valley HealthminorChannel Partner/ Reseller/ DistributorHealthcare provider partnership for potential distribution of Bewe to patients in health system.

Scale indicators6 records

Recent moves1 record

Expansion highlights6 records

Bewelab SA competitors and assessment

Company assessment

Direct peers

  • Noom: Consumer-facing digital weight management app combining psychology, coaching, and food logging. Directly comparable as a behavioral-change weight-management platform competing for the same individual consumers and B2B wellness buyers.
  • Virta Health: Digital therapeutic for type 2 diabetes reversal and weight management, sold enterprise to health plans and employers. Comparable as a clinically validated, payer-reimbursed digital therapeutic addressing diet-related metabolic conditions.
  • mySugr (Roche): Digital therapeutic app for diabetes self-management with consumer and B2B channels. Comparable as a clinically validated, gamified chronic-condition digital health app with payer/employer distribution.
  • WellDoc: Digital therapeutics platform for chronic disease management including diabetes and cardiovascular, with payer and provider B2B channels. Comparable as an enterprise digital therapeutic targeting diet-related chronic conditions.
  • Omada Health: Digital therapeutic platform targeting diabetes prevention and weight management via behavior change, with enterprise B2B distribution through health plans and employers — closely aligned with Bewe's B2B insurance/employer strategy.
  • Akili Interactive: Digital therapeutic company delivering cognitive interventions through video games (e.g., EndeavorRx). Closely aligned with Bewe's game-based neuroscience approach and digital therapeutic regulatory positioning.
  • Liva Healthcare: European digital health platform for lifestyle change and weight management, sold through insurers and healthcare providers. Comparable in geography, B2B payer distribution model, and behavioral-change focus.

Broad incumbents

  • WW International (Weight Watchers): Established incumbent in weight management with consumer subscription and B2B wellness offerings. A broad competitor in the same end-customer problem space (weight/craving reduction) but with a much wider portfolio.
  • Headspace Health: Digital mental health and mindfulness platform with B2B enterprise distribution. Comparable as a behavioral-change digital health app monetized via consumer subscriptions and employer/payer partnerships.

Emerging players

  • CureApp: Japanese digital therapeutic company developing software-based treatments for nicotine addiction and other behavioral conditions. Comparable as an emerging digital therapeutics player using software interventions for addiction/craving reduction.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Bewelab SA social profiles

Digital presence

Bewelab SA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bewelab SA leadership team

Management profile

Number of profiles

Profiles3 records

Bewelab SA funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bewelab SA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bewelab SA

What does Bewelab SA do?

Bewe Lab develops Bewe Coaching, a neuroscience-backed mobile gaming app that retrains the brain's reward system to reduce food cravings through neuroplasticity-based behavioral interventions. Users play 3-5 minutes daily for 1-3 weeks, with mini-games (Go/NoGo, approach-avoidance, time-constrained choice) targeting specific food categories such as sodas (free Swiss module) and additional paid modules (e.g., chocolate, chips) at CHF 7.90 per category.

Is Bewelab SA a public or private company?

Bewelab SA is a private company. It is classified as venture growth investor backed and is currently operating.

When was Bewelab SA founded?

Bewelab SA was founded in 2021. It employs 11 to 50 people.

Where is Bewelab SA based?

Bewelab SA is headquartered in Fribourg, Switzerland, in the Europe region.

How does Bewelab SA make money?

Two revenue lines are on record. Consumer In-App Purchases (Freemium) is the primary driver. The others are B2B Enterprise Licensing.

Who are Bewelab SA's main competitors?

Direct peers on record are Noom, Virta Health, mySugr (Roche), WellDoc, Omada Health, Akili Interactive and Liva Healthcare. Broad incumbents are WW International (Weight Watchers) and Headspace Health. CureApp is listed as an emerging player.

Does Bewelab SA have an API?

No public API is recorded for Bewelab SA.

What industry is Bewelab SA in?

Bewelab SA's product category is Digital Health Software. Its primary akta.pro industry code is HLAFACAK, Eating Disorder Treatment Programs, with a secondary code of HSADAFAO, Corporate/Workplace Nutrition & Weight Management Programs.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioAlpsBewe’s Biopôle journey comes full circle with Pre-Clinical Top-UpBewe, a University of Fribourg spin-off, received a Pre-Clinical Top-Up of CHF 250,000 after securing CHF 2m from investors. The funding will support clinical studies for its digital therapy combined with anti-obesity medication. The company plans to enroll patients in US and Swiss trials and launch an AI-powered Digital Twin platform.startupticker.chBewe awarded Biopôle Pre-Clinical Top-UpBewe has been awarded the Pre-Clinical Top-Up, a CHF 250,000 convertible loan from Biopôle SA, to accelerate clinical studies for its neuroscience-based digital intervention targeting unhealthy food cravings. This funding follows a previous CHF 2m investment from entities including Arcanys Ventures and Capital Risque Fribourg, enabling Bewe to collaborate with Stanford University and Swiss clinics on obesity treatment outcomes. The company plans to enroll patients in US and Swiss trials while launching an AI-powered Digital Twin platform to support its expansion into other addictive behaviors.startupticker.chData science and AI start-ups secure supportThe Canton of Vaud and Swiss Data Science Center have selected two AI start-ups, Bewe Lab SA and Perivision SA, alongside projects from Bobst and the cantonal administration, to receive one-year technical support under a 7.5 million franc collaborative innovation program for 2024-2028. Separately, Neurosoft Bioelectronics has been awarded a computational support grant by the Swiss AI Initiative to access Alps, currently ranked #8 globally, to train large-scale neural decoding models using its proprietary soft electrode technology. The program aims to develop scalable applied solutions with economic and societal impact in life sciences, energy, sustainability, and digital transformation.